In agreement with these findings, several lines of evidence indicated that enhanced phosphorylation of PERK and eIF2α in the AD brain is associated with increased amyloidogenic APP processing [214,215,216] through increased BACE1 expression [220,221]. This evidence concerns the gene BACE1 and Alzheimer disease.